SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-17-015120
Filing Date
2017-08-03
Accepted
2017-08-03 08:07:03
Documents
6
Period of Report
2017-08-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K- Q2 2017- RESULTS bioa-8k_20170801.htm 8-K 46892
2 EX-10.1 bioa-ex101_9.htm EX-10.1 176699
3 EX-10.2 bioa-ex102_7.htm EX-10.2 42981
4 EX-10.3 bioa-ex103_10.htm EX-10.3 224230
5 EX-99.1 bioa-ex991_8.htm EX-99.1 157866
6 GRAPHIC g20170803111646004854.jpg GRAPHIC 51754
  Complete submission text file 0001564590-17-015120.txt   721461
Mailing Address 3850 ANNAPOLIS LANE NORTH, SUITE 180 PLYMOUTH MN 55447-5476
Business Address 3850 ANNAPOLIS LANE NORTH, SUITE 180 PLYMOUTH MN 55447-5476 612-747-4423
BioAmber Inc. (Filer) CIK: 0001534287 (see all company filings)

IRS No.: 980601045 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35905 | Film No.: 171002914
SIC: 2860 Industrial Organic Chemicals